Creative Medical Secures Exosome Patent Boosting Diabetes Immunotherapy IP
Creative Medical Technology gains a U.S. patent for exosome‑based immunotherapy, strengthening its diabetes platform and positioning for future licensing in a growing stem‑cell market.
3 minutes to read